entity

Aβ Oligomers

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Aβ Oligomers: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

31Connections
1Hypotheses
7Analyses
26Outgoing
5Incoming
0Experiments
8Debates

No AI portrait yet

Outgoing (26)

TargetRelationTypeStr
tau hyperphosphorylationtriggersmechanism0.90
microgliaactivatescell_type0.90
tau missortingcausesmechanism0.90
synapse losscausesphenotype0.90
Hippocampal Neuronal Damagecausesphenotype0.85

Incoming (5)

SourceRelationTypeStr
24713000impairpaper0.90
24713000causepaper0.90
30867420reducepaper0.90
30867420inducepaper0.60
CD36regulatesprotein0.50

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Closed-loop focused ultrasound targeting CA1 PV interneurons 0.729 Alzheimer's disease Circuit-level neural dynamics in neurode

Mentioning Analyses (7)

Scientific analyses that reference this entity

Closed-loop optogenetic targeting PV interneurons to restore theta-gamma couplin

Alzheimer's disease | 2026-04-28 | 7 hypotheses Top: 0.700

Does tau dendritic missorting persist independently after Aβ clearance, maintain

neurodegeneration | 2026-04-25 | 7 hypotheses Top: 0.740

Does pericyte senescence drive BBB breakdown or result from neurodegeneration as

neurodegeneration | 2026-04-25 | 6 hypotheses Top: 0.720

Clinical Trial Landscaping for Alzheimer's Disease Therapeutics

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.629

What is the optimal therapeutic window during preclinical AD for epigenetic repr

neurodegeneration | 2026-04-07 | 7 hypotheses Top: 0.643

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (5)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting [PMID:38513667] Zhang D, Zhang W, Ming C, Gao X, Yuan H, Neuron 2024 0
The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disea [PMID:38852117] Balusu S, De Strooper B Acta neuropathologica 2024 0
Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease. [PMID:34069890] Burillo J, Marqués P, Jiménez B, Gonzále Cells 2021 0
Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in tra [PMID:17021169] ["Oakley, Holly", "Cole, Sarah L", "Loga The Journal of neuroscience : 2006 0
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road [PMID:12130773] ["Hardy, John", "Selkoe, Dennis J"] Science (New York, N.Y.) 2002 0

Debates (8)

Multi-agent debates referencing this entity

Structured research brief for hypothesis h-var-e95d2d1d86: Closed-loop optogenet

closed · Rounds: 4 · Score: 0.72 · 2026-04-28

Does tau dendritic missorting persist independently after Aβ clearance, maintain

closed · Rounds: 4 · Score: 0.65 · 2026-04-25

Does pericyte senescence drive BBB breakdown or result from neurodegeneration as

closed · Rounds: 4 · Score: 0.68 · 2026-04-25

What is the role of microglial synaptic pruning in Alzheimer's disease and other

closed · Rounds: 4 · Score: 0.68 · 2026-04-22

The abstract indicates SPP1 upregulation occurs in perivascular macrophages and

closed · Rounds: 4 · Score: 0.67 · 2026-04-22

The debate identified temporal specificity as a critical weakness - when exactly

closed · Rounds: 4 · Score: 0.68 · 2026-04-21

What is the current clinical trial landscape for AD therapeutics, and which mech

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

Is the amyloid concentration in AD clinical trials rational given lecanemab's ap

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

Related Research

Hypotheses and analyses mentioning Aβ Oligomers in their description or question text

No additional research found